Community and nursing home residents with carbapenemase-producing klebsiella pneumoniae infection

Infection Control and Hospital Epidemiology

Volumn 32, Issue 6, 2011, Pages 629-631

  Mills, John ^a   Chapin, Kimberle ^a,b   Andrea, Sarah ^b   Furtado, Gary ^b   Mermel, Leonard ^a,b  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CARBAPENEMASE PRODUCING KLEBSIELLA PNEUMONIAE INFECTION; CLINICAL ARTICLE; FEMALE; FUNCTIONAL STATUS; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; KLEBSIELLA PNEUMONIAE INFECTION; LETTER; MALE; MEDICAL CARE; NURSING HOME PATIENT;

AGED; AGED, 80 AND OVER; BACTERIAL PROTEINS; BETA-LACTAMASES; CARRIER STATE; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; NURSING HOMES; PREVALENCE; RISK FACTORS;

EID: 79957947134     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/660202     Document Type: Letter

References (9)

1. Nordmann P, Cuzon G, Nass T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009;9:228-236.
2. Ben-David D, Maor Y, Keller N, et al. Potential role of active surveillance in the control of a hospital-wide outbreak of car-bapenem-resistant Klebsiella pneumoniae infection. Infect Control Hosp Epidemiol 2010;31:620-626.
3. Patel G, Huprikar S, Factor S, Jenkins S, Calfee D. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect ControlHosp Epidemiol 2008;29:1099-1106.
4. Centers for Disease Control and Prevention. Laboratory protocol for detection of carbapenem-resistant or carbapenemase-producing, Klebsiella spp. and E. coli from rectal swabs. Atlanta: Centers for Disease Control and Prevention, 2009. http:// www.cdc.gov/ncidod/dhqp/pdf/ar/Klebsiella_or_Ecoli.pdf. Accessed April 9, 2010.
5. Centers for Disease Control and Prevention. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep 2009;58:256-260.
6. Munoz-Price L, Hayden M, Lolans K, et al. Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae at a long-term acute care hospital. Infect Control Hosp Epidemiol 2010;31:341-347.
7. Falagas M, Rafailidis P, Kofteridis D, et al. Risk factors of car-bapenem-resistant Klebsiella pneumoniae infections: a matched case-control study. J Antimicrob Chemother 2007;60:1124-1130.
8. Hussein K, Sprecher H, Mashiach T, Oren I, Kassis I, Finkelstein R. Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular isolates, and susceptibility patterns. Infect Control Hosp Epidemiol 2009;30:666-671.
9. O'Fallon E, Schreiber R, Kandel R, D'Agata E. Multidrug-resistant gram-negative bacteria at a long-term care facility: assessment of residents, healthcare workers, and inanimate surfaces. Infect Control Hosp Epidemiol 2009;30:1172-1179.